¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"occlusion compound"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
normal occlusion
Á¤»ó¸Â¹°¸², Á¤»ó±³ÇÕ
occlusion
1. ¸·Èû, Æó»ö, Æó¼â 2. ¸Â¹°¸², ±³ÇÕ 3. °¡¸²
occlusion amblyopia
°¡¸²¿øÀξà½Ã
occlusion rim
±³ÇÕÅ×
posterior occlusion
¾Æ·¡Åεڸ¹°¸², ¿ø½É±³ÇÕ
punctal occlusion
´«¹°Á¡Æó¼â, ´©Á¡Æó¼â
retrusive occlusion
¾Æ·¡Åεڸ¹°¸², ¿ø½É±³ÇÕ
stabilized occlusion
¾ÈÁ¤¸Â¹°¸², ¾ÈÁ¤±³ÇÕ
aromatic compound
¹æÇâÁ·ÈÇÕ¹°
asymmetric compound
ºñ´ëĪÈÇÕ¹°
acyclic compound
¹«°í¸®ÈÇÕ¹°
addition compound
÷°¡ÈÇÕ¹°
adsorption compound
ÈíÂøÈÇÕ¹°
aliphatic compound
Áö¹æÁ·ÈÇÕ¹°
amphoteric compound
¾ç¼ºÈÇÕ¹°
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
occlusion
¸·Èû, Æó»ö, ¸Â¹°¸², °¡¸², Æó¼â
occlusion test
¸Â¹°¸²°Ë»ç, ±³ÇÕ°Ë»ç
occlusion therapy
°¡¸²Ä¡·á
posterior occlusion
(¢¡distocclusion) ¾Æ·¡Åεڹ°¸², ¿ø½É¸Â¹°¸², ¿ø½É±³ÇÕ
punctal occlusion
´«¹°Á¡Æó¼â, ´©Á¡Æó¼â
retrusive occlusion
(¢¡distocclusion) ¾Æ·¡Åεڹ°¸², ¿ø½É¸Â¹°¸², ¿ø½É±³ÇÕ
stabilized occlusion
¾ÈÁ¤¹°¸², ¾ÈÁ¤±³ÇÕ
traumatic occlusion
¿Ü»ó¹°¸²
acyclic compound
¹«°í¸®ÈÇÕ¹°
addition compound
÷°¡ÈÇÕ¹°
adsorption compound
ÈíÂøÈÇÕ¹°
aliphatic compound
Áö¹æÁ·ÈÇÕ¹°
amphoteric compound
¾ç¼ºÈÇÕ¹°
aromatic compound
¹æÇâÁ·ÈÇÕ¹°
asymmetric compound
ºñ´ëĪÈÇÕ¹°
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
hemiretinal vein occlusion
Àý¹Ý¸Á¸·Á¤¸ÆÆó¼â(Áõ)
heterocyclic compound
ÇìÅ×·Î°í¸®ÈÇÕ¹°, ÀÌÁ¾¿øÀÚ°í¸®ÈÇÕ¹°.
heteropolar compound
ÀÌ(¼º)±ØÈÇÕ¹°(ì¶àõпûùùêÚª).
homeopolar compound
µ¿±ØÈÇÕ¹°.
homocyclic compound
µ¿¼Òȯ½ÄÈÇÕ¹°.
homopolar compound
µ¿±ØÈÇÕ¹°(ÔÒпûùùêÚª).
hyperfunctional occlusion
°úµµ±³ÇÕ(°úʱ³ÇÕ).
hyperfunctional occlusion
°úµµ±³ÇÕ(ΦöôÎá ùê).
hypothetical normal occlusion
°¡»óÁ¤»ó±³ÇÕ(Ê£ßÌïáßÈÎáùê).
ideal occlusion
ÀÌ»ó±³ÇÕ(ìµßÌÎáùê).
impending occlusion
Àý¹ÚÆó¼â
impression compound
Àλó¿ë ÄÄÆÄ¿îµå.
individual normal occlusion
°³¼ºÁ¤»ó±³ÇÕ (ËÁàõïáßÈÎáùê).
inorganic compound
¹«±âÈÇÕ¹°.
polyfunctional compound
´Ù°ü´ÉÈÇÕ¹°(ÒýίÒöûùùêÚª).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
cerebral occlusion
³úµ¿¸ÆÆó¼â(ÒàÔÑØæøÍáð).
chronic arterial occlusion
¸¸¼ºµ¿¸ÆÆó¼â.
coronary occlusion
°ü(»ó)(µ¿¸Æ)Æó»ö(Áõ)(¡øÍßáñø).
curve of occlusion
±³ÇÕ¸¸°î(ÎáùêØ¶ÍØ).
distal occlusion
¸»´ÜºÎÆó¼â(ØÇӮݻøÍáð), ÈÄÃø±³ÇÕ(ýö°Îáùê).
distal occlusion
¿øÀ§ºÎÆó¼â(¿øÀ§ºÎÆó¼â), ÈÄÃø±³ÇÕ(ÈÄÃø±³ÇÕ).
eccentric occlusion
Æí½É±³ÇÕ(ø¶ãýÎáùê).
edge to edge occlusion
Àý´Ü±³ÇÕ(ôîÓ¨ Îáùê).
end-to-end bite =e. occlusion
´Ü´Ü±³ÇÕ.
equilibration of occlusion
±³ÇÕÆòÇü(ÎáùêøÁû¬).
false occlusion
ºÎÁ¤±³ÇÕ(ÝÕïÒÎáùê).
habitual occlusion
½À°ü¼º ±³ÇÕ(¡Îáùê).
hemiretinal vein occlusion
Àý¹Ý¸Á¸·Á¤¸ÆÆó¼â(Áõ)
hyperfunctional occlusion
°úµµ±³ÇÕ(°úʱ³ÇÕ).
hyperfunctional occlusion
°úµµ±³ÇÕ(ΦöôÎá ùê).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½